Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma

[1]  M. Kurano,et al.  Association between serum autotaxin or phosphatidylserine‐specific phospholipase A1 levels and melanoma , 2018, The Journal of dermatology.

[2]  M. Kurano,et al.  Evidence Suggests Sphingosine 1‐Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P2 and S1P3 Expression in Colon Cancer , 2017, Clinical colorectal cancer.

[3]  M. Kurano,et al.  Analysis of glycero-lysophospholipids in gastric cancerous ascites[S] , 2017, Journal of Lipid Research.

[4]  K. Hasegawa,et al.  Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels , 2016, PloS one.

[5]  K. Hasegawa,et al.  Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence , 2016, PloS one.

[6]  J. Aoki,et al.  Phosphatidylserine-specific phospholipase A1 (PS-PLA1) expression in colorectal cancer correlates with tumor invasion and hematogenous metastasis. , 2015, Anticancer research.

[7]  J. Aoki,et al.  Lysophosphatidic acid as a lipid mediator with multiple biological actions. , 2015, Journal of biochemistry.

[8]  Y. Yatomi,et al.  Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway. , 2014, Anticancer research.

[9]  J. Aoki,et al.  Novel lysophosphoplipid receptors: their structure and function , 2014, Journal of Lipid Research.

[10]  Weidong Yu,et al.  Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway. , 2013, Histology and histopathology.

[11]  E. Gendaszewska-Darmach,et al.  Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function. , 2013, Biochimie.

[12]  S. Higashiyama,et al.  TGFα shedding assay: an accurate and versatile method for detecting GPCR activation , 2012, Nature Methods.

[13]  Y. Okamoto,et al.  Sphingosine‐1‐phosphate signaling in physiology and diseases , 2012, BioFactors.

[14]  D. Bratton,et al.  Emerging roles for lysophosphatidylserine in resolution of inflammation. , 2012, Progress in lipid research.

[15]  R. Leurs,et al.  Quantitative expression profiling of G‐protein‐coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target , 2011, Pigment cell & melanoma research.

[16]  H. El‐Serag,et al.  Hepatocellular carcinoma. , 2011, The New England journal of medicine.

[17]  K. Sangkuhl,et al.  Altered Immune Response in Mice Deficient for the G Protein-coupled Receptor GPR34* , 2010, The Journal of Biological Chemistry.

[18]  N. Hayashi,et al.  A novel enzyme immunoassay for the determination of phosphatidylserine-specific phospholipase A(1) in human serum samples. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[19]  Sun Young Lee,et al.  Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells. , 2008, Biochemical and biophysical research communications.

[20]  M. Ebisawa,et al.  Identification of a lysophosphatidylserine receptor on mast cells. , 2006, Biochemical and biophysical research communications.

[21]  D. Im,et al.  Lysophosphatidylserine Stimulates L2071 Mouse Fibroblast Chemotactic Migration via a Process Involving Pertussis Toxin-Sensitive Trimeric G-Proteins , 2006, Molecular Pharmacology.

[22]  L. Garrett-Sinha,et al.  The Ets Factors PU.1 and Spi-B Regulate the Transcriptionin Vivo of P2Y10, a Lymphoid Restricted Heptahelical Receptor* , 1999, The Journal of Biological Chemistry.

[23]  M. Blennerhassett,et al.  Lysophosphatidylserine potentiates nerve growth factor-induced differentiation of PC12 cells , 1998, Neuroscience Letters.

[24]  Hiroyuki Arai,et al.  Serine Phospholipid-specific Phospholipase A That Is Secreted from Activated Platelets , 1997, The Journal of Biological Chemistry.

[25]  A. Bruni,et al.  Role of a serum phospholipase A1 in the phosphatidylserine‐induced T cell inhibition , 1993, FEBS letters.

[26]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[27]  R. Plumb,et al.  The exogenous lipid requirement for histamine release from rat peritoneal mast cells stimulated by concanavalin A , 1979, FEBS letters.

[28]  T. W. Martin,et al.  Interactions of lysophospholipids and mast cells , 1979, Nature.